Beretta Holding S.A. Launches Cash Tender Offer for Sturm, Ruger & Company, Inc. Shares

Warburg Pincus Launches Tender Offer to Take J.S.B. Co. Private

June 15, 2026

Real Estate

Warburg Pincus announced plans to launch a tender offer to acquire all common shares and stock options of J.S.B. Co., Japan’s integrated student housing and services platform, at specified per-share and per-option prices. J.S.B.’s board supports the transaction, and Warburg Pincus has secured support agreements from its two largest shareholders (Oka Family and HIKARI TSUSHIN Group), representing over 58% of outstanding shares.

Frasers Group plc to Acquire Remaining Shares of HUGO BOSS AG

June 10, 2026

Consumer Products

Frasers Group plc (the “Bidder”) announced a voluntary public takeover offer to acquire all non-held shares of HUGO BOSS AG for €38.00 in cash per share. The offer acceptance period ran from June 25, 2026 to August 13, 2026 (including an additional acceptance period), with the offer condition satisfied on July 27, 2026 and settlement scheduled within seven trading days after the final acceptance announcement.

Genmab A/S Acquires Merus N.V. via Tender Offer

December 12, 2025

Biotechnology

Genmab A/S, through its wholly owned purchaser Genmab Holding II B.V., completed a tender offer to acquire outstanding common shares of Merus N.V. for $97.00 per share and commenced a subsequent offering period. The acquisition adds Merus' lead late‑stage oncology asset petosemtamab to Genmab's portfolio, expanding its antibody therapeutics pipeline and expected to be accretive to EBITDA by 2029.

KKR Launches Tender Offer to Take FUJI SOFT Private

November 7, 2024

IT Services

KKR, through an Offeror owned by funds it manages (FK Co., Ltd.), will commence a second-stage tender offer for FUJI SOFT Inc. at ¥9,451 per share after acquiring ~33.9% in a first-stage offer. FUJI SOFT's board has unanimously recommended shareholders tender into the second offer; KKR says the privatization will allow it to work with management to enhance corporate value.

Alfasigma to Acquire Intercept Pharmaceuticals for $19.00 per Share

September 26, 2023

Pharmaceuticals

Alfasigma S.p.A. entered into a definitive merger agreement to acquire Intercept Pharmaceuticals, Inc. for $19.00 per share in cash, representing an 82% premium to Intercept’s closing price on September 25, 2023. The deal is structured as a cash tender offer followed by a second-step merger and is expected to close by the end of 2023, pending conditions including a minimum tender and regulatory requirements.

Corteva Acquires Stoller Group

November 30, 2022

Agriculture

Corteva, Inc. signed a definitive agreement to acquire Houston-based Stoller Group, a leading independent biologicals and plant-health company with operations in more than 60 countries and forecasted 2022 revenues of over $400 million. Corteva will pay $1.2 billion in cash (≈12x expected 2022 EBITDA); the deal is expected to close in the first half of 2023 and is intended to accelerate and expand Corteva’s Biologicals capabilities and commercial reach.